Pengxian Tao

Lanzhou University Second Hospital

Papers

1

Total Citations

24

H-Index

1

About

Dr. Pengxian Tao is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, with a particular emphasis on robotic-assisted surgery. His most cited work, a 2019 retrospective propensity score-matched study, systematically assessed complications after robotic-assisted total versus distal gastrectomy for advanced gastric cancer using the Clavien–Dindo classification. This landmark study, with 24 citations, provided critical evidence that while robotic-assisted distal gastrectomy is safe and feasible for advanced gastric cancer, total gastrectomy remains technically challenging with distinct postoperative risks. Dr. Tao's contributions have helped refine surgical decision-making, offering surgeons a clearer understanding of complication profiles to optimize patient outcomes. His work bridges the gap between technological innovation and clinical practice, demonstrating how robotic platforms can be leveraged to improve surgical precision while acknowledging their limitations. By systematically evaluating safety and feasibility, Dr. Tao has established himself as a key voice in the evolution of robotic gastrectomy, influencing both surgical protocols and future research directions in advanced gastric cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Systematic assessment of complications after robotic-assisted total versus distal gastrectomy for advanced gastric cancer: A retrospective propensity score-matched study using Clavien–Dindo classification
24 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Lanzhou University Second Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago